SciELO - Scientific Electronic Library Online

 
vol.27 número1ALTERACIONES HEMATOLÓGICAS EN GESTANTES CON COVID-19 RESIDENTES EN LA ALTURA índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Médica La Paz

versão On-line ISSN 1726-8958

Resumo

AMARU, Ricardo et al. HIGH DOSES OF COBALAMIN AND FOLIC ACID IN POST-COVID-19 LEUKOPENIA TREATMENT. Rev. Méd. La Paz [online]. 2021, vol.27, n.1, pp.9-14. ISSN 1726-8958.

Introduction: Leukopenia is one of the persistent manifestations in patients who have suffered from COVID-19 and its characteristics are similar to those patients with vitamin B12 and folic acid deficiency. Objective: To show the usefulness high doses of vitamin B12 and folic acid in post COVID-19 leukopenia treatment. Material and methods: Retrospective descriptive cross-sectional study. Demographic, clinical and laboratory data were collected from patients (n = 22) with post COVID-19 leukopenia who were treated with doses of vitamin B12 and folic acid. Follow-up of clinical and laboratory data corresponding to diagnosis as well as 4 and 8 weeks after treatment was assessed. Results: Leukopenia was totally reversed, leukocytes increased and reached normal values. Hemoglobin levels increased, although without reaching normal values. Lymphocytes increased within normal parameters though they were not decreased at diagnosis. MCV levels remained with slight modifications, and platelets without modifications. Patients symptoms subsided after 2 months treatment. Conclusion: Data obtained can serve as part of treatment rationale in post-COVID-19 syndrome.

Palavras-chave : COVID-19; SARS-CoV-2; leukopenia; vitamin B12; folic acid.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons